secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2026-02-17T23:59:59+00:00
Accession:  0001628280-26-008641
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast Q4 revenue falls 37% to $75.1M; net loss $18.1M, guides FY26 rev $270-300M
--------------------------------------------------------------------------------

- Revenue $75.1M, down 36.9% YoY; active earning coaches down 40.6% to 16,100.
- Net loss $18.1M ($1.65 EPS) includes $12.1M non-cash tax valuation allowance ($1.10/sh).
- Full year 2025 revenue $385.8M (-36% YoY); net loss $18.7M (-$1.70 EPS).
- Guides Q1 2026 rev $65-80M, loss $0.15-$0.70/sh; FY26 rev $270-300M, loss $1.55-$2.75/sh.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828026008641/0001628280-26-008641-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828026008641/med-20260217.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-008641

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer